The U.S. Food and Drug Administration (FDA) has agreed to review Adamas Pharmaceutical’s application asking that oral Gocovri (…
Articles by Patricia Inácio, PhD
People carrying gene variants that lower leucine-rich repeat kinase 2 (LRRK2) levels — an enzyme whose mutated form is one of…
Seelos Therapeutics announced it is beginning, earlier than expected, a preclinical study into its investigational gene therapy candidate for Parkinson’s disease called…
Current or past tobacco smokers are at lower risk of developing Parkinson’s disease than lifelong non-smokers, a long-term study of doctors…
GB Sciences has been granted a patent from the U.S. Patent and Trademark Office (USPTO) covering the use of…
Researchers have developed short gene promoters — structures that act like switches to turn on genes — that may boost…
Zhichan powder, a traditional Chinese medicine, contains several active compounds that may be of therapeutic value in Parkinson’s disease,…
The levels of levodopa, one of the gold-standard treatments in Parkinson’s disease, may be assessed using a fast,…
The Phase 2 RESTORE-1 trial testing the investigational gene therapy VY-AADC has suspended the screening and enrollment of…
Anavex Life Sciences announced plans to continue to screen and enroll patients into its active trials for Alzheimer’s disease…